Resultados de la búsqueda 51-60 of 13334 for Estradiol Valerate

  1. Centros vasculares - Ensayos clínicos - Mayo Clinic

    The Specific Aims of this study are: 1. To identify the genetic causes of bicuspid aortic valve disease and its associated thoracic aortic disease. 2. To ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    ... estrogen and progesterone receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced ...

  3. Mayo Clinic Obstetrics and Gynecology Physician Update - January 2026

    Page 1.

  4. Mayo Clinic Urology Physician Update � April 2026

    Page 1.

  5. Enfermedades de trasmisión sexual

    Adamson PC, et al. Point-of-care testing for sexually transmitted infections: A review of recent developments. Archives of Pathology and Laboratory Medicine ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to determine how well tafasitamab, lenalidomide and venetoclax work in treating patients with mantle cell lymphoma ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...